Candriam Equities L Biotech.C USD Acc/ LU0108459040 /
| NAV9/29/2023 | Chg.-3.4400 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 730.7300USD | -0.47% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 10/2/2023 | Public WebStation Live Factsheet | 2023 | English | - |
| 9/11/2023 | Prospectus | 2023 | English | 3,638.77 KB |
| 9/11/2023 | Prospectus | 2023 | German | 3,801.35 KB |
| 9/11/2023 | PRDE20230911-0001932949.pdf | 2023 | German | 264.91 KB |
| 6/30/2023 | Semi-annual report | 2023 | English | 1,982.78 KB |
| 6/30/2023 | Semi-annual report | 2023 | German | 2,086.39 KB |
| 12/31/2022 | Account statment | 2022 | English | 6,504.26 KB |
| 12/31/2022 | Account statment | 2022 | German | 4,696.56 KB |
| 12/1/2022 | Key Investor Information | 2022 | German | 367.75 KB |